Mechanisms of resistance to daptomycin in Enterococcus faecium

Antimicrobial Agents and Chemotherapy
Clemente I MonteroPatrick R Murray

Abstract

In this study, we investigated the clonal emergence of daptomycin-resistant Enterococcus faecium strains isolated from a patient with leukocyte adhesion deficiency syndrome. The resistance mechanism in these strains is independent of either equivalent point mutations previously described for Staphylococcus aureus or daptomycin inactivation mechanisms identified in soil bacteria.

References

Mar 7, 2002·Microbes and Infection·Brett D Shepard, Michael S Gilmore
Mar 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher F Carpenter, Henry F Chambers
Dec 8, 2004·Journal of Clinical Microbiology·Florence DepardieuPatrice Courvalin
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·James S LewisJames H Jorgensen
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A MangiliD H Hamer
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Silvia Munoz-PriceJohn P Quinn
Oct 7, 2005·Journal of Clinical Microbiology·M K HaydenR A Weinstein
Jan 21, 2006·Science·Vanessa M D'CostaGerard D Wright
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George SakoulasGeorge M Eliopoulos
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B PatelFred C Tenover
May 26, 2006·Antimicrobial Agents and Chemotherapy·Lisa FriedmanJared A Silverman
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H S SaderR N Jones
Aug 18, 2006·The New England Journal of Medicine·Vance G FowlerUNKNOWN S. aureus Endocarditis and Bacteremia Study Group
Oct 13, 2006·The Journal of Antimicrobial Chemotherapy·Jacques VouillamozJosé M Entenza
Aug 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W Boucher, George Sakoulas

❮ Previous
Next ❯

Citations

Jun 5, 2010·The Journal of Biological Chemistry·Lars Robbel, Mohamed A Marahiel
May 27, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yingmei LiuHui Wang
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·P M Hawkey
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·R E Warren
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·David M Livermore
Apr 20, 2011·Antimicrobial Agents and Chemotherapy·Kelli L PalmerMichael S Gilmore
May 8, 2009·Journal of Clinical Microbiology·Christoph SchoenStephan Mielke
Jun 6, 2009·Annual Review of Biochemistry·John W Kozarich
Nov 10, 2009·Future Microbiology·Rob Jl Willems, Willem van Schaik
Feb 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theodoros KelesidisDavid A Pegues
Jun 29, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E McElvania TeKippeC-A D Burnham
Sep 8, 2010·Expert Review of Anti-infective Therapy·Daniel Curcio
Oct 14, 2008·Expert Review of Anti-infective Therapy·Cesar A Arias, Barbara E Murray
Feb 7, 2012·Enfermedades infecciosas y microbiología clínica·Emilia Cercenado
Jan 4, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Hong ShenBin Cao
Nov 17, 2009·Infectious Disease Clinics of North America·Luke F ChenKeith S Kaye
May 17, 2008·Plasmid·Marcin FilutowiczRavi Shankar
Jan 22, 2009·Chembiochem : a European Journal of Chemical Biology·Matthias Strieker, Mohamed A Marahiel
Nov 28, 2013·Zoonoses and Public Health·T Kelesidis
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mini KambojKent A Sepkowitz
Feb 19, 2010·Expert Opinion on Pharmacotherapy·Christos Kosmidis, Donald P Levine
Jan 15, 2015·Biochimica Et Biophysica Acta·Jianguo LiRoger W Beuerman
Jun 16, 2016·Frontiers in Microbiology·Ana M Guzman PrietoRob J L Willems
Jan 8, 2014·Expert Review of Anti-infective Therapy·Vincent Cattoir, Jean-Christophe Giard
Oct 30, 2014·The Annals of Pharmacotherapy·Ruchi Patel, Jason C Gallagher
Oct 24, 2017·The Journal of Antimicrobial Chemotherapy·Mohsen HeidaryMehdi Goudarzi
Feb 5, 2021·Frontiers in Genetics·Vinicius A C de AbreuSintia Almeida
Jul 13, 2019·Microbiology Spectrum·Elizabeth FioreMichael S Gilmore
Apr 23, 2020·Enfermedades infecciosas y microbiología clínica·Alejandra AsenjoJuan-Ignacio Alós
Jun 6, 2021·Enfermedades Infecciosas Y Microbiologia Clinica·Alejandra AsenjoJuan-Ignacio Alós
Sep 16, 2017·The Journal of Organic Chemistry·Leo CorciliusRichard J Payne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.